The current valuation score of Aquestive Therapeutics Inc is 8.84, ranking 42 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -6.07, which is -89.29% below the recent high of -0.65 and -681.46% above the recent low of -47.40.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.